Ionis Pharmaceuticals Inc banner

Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 72.34 USD -3.28% Market Closed
Market Cap: $11.9B

Wall Street
Price Targets

IONS Price Targets Summary
Ionis Pharmaceuticals Inc

Wall Street analysts forecast IONS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IONS is 92.16 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.

Lowest
Price Target
46.46 USD
36% Downside
Average
Price Target
92.16 USD
27% Upside
Highest
Price Target
115.5 USD
60% Upside
Ionis Pharmaceuticals Inc Competitors:
Price Targets
NCSM
NCS Multistage Holdings Inc
-22% Downside
QLYS
Qualys Inc
48% Upside
LAND
Gladstone Land Corp
-11% Downside

Revenue
Forecast

17% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat
17% / Year
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
5%
Average Beat

For the last 14 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 17%. The projected CAGR for the next 3 years is 26%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IONS's stock price target?
Price Target
92.16 USD

According to Wall Street analysts, the average 1-year price target for IONS is 92.16 USD with a low forecast of 46.46 USD and a high forecast of 115.5 USD.

What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
26%

For the last 14 years the compound annual growth rate for Ionis Pharmaceuticals Inc's revenue is 17%. The projected CAGR for the next 3 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett